Main Article Content



Terminalia arjuna is an evergreen tree that belongs to the family Combretaceae and has widespread traditional medicinal uses. Although the whole plant part has some medicinal properties owing to the presence of specific bioactive compounds, but the bark part of the plant prominently being used to treat various ailments by ethnic traditional healers (cardiovascular, skin, asthama, hypertension, unrinary tract disorders) . The main bioactive constituent of the plant is glycosides (cardiac glucoside), flavonoids (arjunone and arjunolone), and triterpenoids (arjunolic acid) that are responsible for its cardioprotective, antioxidant, wound healing (tannin and saponin found in bark part), antitumour (especially against human hepatoma), anti-inflammatory, anti-diabetic, antimicrobial (broad spectrum effect against many gram negative bacteria) activities. Various pharmacological studies indicated its protective action against toxicities induced by certain heavy metals (As) and toxic compounds (NaF and Acetaminophen) owing to the potent antioxidant properties of one of the bioactive agent Arunolic acid. The plant has many more potential in terms of its therapeutic uses that can be explored by referring to the traditional ethnomedicinal experts and literature and thereby can be scientifically validated so that its toxicity side effects and dosage can be measured and quantified. The present review encompases morphological features, distribution, a few traditional and ethnomedicinal formulations and uses, scientific studies on phytochemical constituents and pharmacological significance of Terminalia arjuna and can be refered for further scientific investigations on the bioactive secondsary metabolites of the plant.

Terminalia arjuna, combretaceae, bark, cardioprotective, antitumour, antioxidant, antiinflamatory

Article Details

How to Cite
Review Article


Chander R, Singh K, Khanna AK, Kaul SM, Puri A, Saxena R, Bhatia G, Rizvi F, Rastogi AK. Antidislipidemic and antioxidant activities of different fractions of T. arjuna stem bark. Indian Journal of Clinical Biochemistry. 2004;19(2):141-148.

Kalola J, Rajani M. Extraction and TLC densitometric determination of triterpenoid acids (Arjungenin, Arjunolic Acid) from Terminalia arjuna Stem Bark Without Interference of Tannins. Chromatographia. 2001;63:475-481.

Nadkarni KM.Terminalia arjuna. Indian Materia Medica Popular Prakashan. India. 2000;1:1198 – 1202.

Yesodharan K, Sujana KA. Ethnomedicinal knowledge among malamalasar tribe of parambikulam wildlife sanctuary, Kerala. Indian J. of Traditional Knowledge. 2007;6(3):481-485.

Paarakh PM. Terminalia arjuna (Roxb.) wt. and arn:A review. Int. J. Pharmacol 2010; 6:515- 534.

Maulik SK. Focused conference group:Natural product:past & future? Role of Terminalia arjuna An Indian medicinal plant in cardiovascular disease. Basic and Clinical Pharmacology& Toxicology. 2010;107:445-446.

Shukla SK, Dwivedi S, Sing SB, Sharma UR. Terminalia arjuna as a therapeutic and preventive modulator in experimentally induced myocardial infarction. Diabetes and vascular disease research 2011; 8:1:80-81.

Gupta R, Singhal S, Goyle A, Sharma VN. Antioxidant and hypocholesterolemic effects of Terminalia arjuna tree-bark powder:a randomized placebo-controlled trial. J. Asso. Physician, India. 2001;49:231- 235.

Kandil FE, Nassar MY. A tannin anti-cancer promoter from Terminalia arjuna. Phytochem. 1998; 47:1567- 1568.

Tripathi VK, Pandey VB, Udupa KN, Rucker G. Arjunolitin, a triterpene glycoside from Terminalia arjuna. Phytochem. 1992;31:349 – 351.

Ahmad MU, Mullah KB, Norin T, and Ulla JK. Terminoic acid, a new trihydroxy triterpene carboxylic acid from the bark of Terminalia arjuna. Indian J. Chem. 1983;22:738- 740.

Sharma PN, Shoeb PN, Kapil RS, Popli SP. Arjunolone—a new flavone from the stem bark of Terminalia arjuna. Indian Journal of Chemistry. 1982;21B:263–264.

Anjaneyulu, ASR, Prasad AVR. Chemical examination of the roots of Terminalia arjuna (Roxb) Wight and Arnt. Phytochem. 1982;21:2057–2060.

Row LR, Murty PS, Subba Rao GSR, Sastry CSP, Rao KJV. Chemical examination of Terminalia species XIII. Isolation and structure determination of arjunic acid, a new trihydroxytriterpene carboxylic acid from the Terminalia arjuna bark. Indian J. Chem. 1970;8:716–721.

Honda T, Murae T, Tsuyuki T, Takahashi T, Sawai M.Arjungenin, Arjunglucoside I, and Arjun glucoside II. A New Triterpene and New Triterpene Glucosides from Terminalia arjuna. Bull. Chem. Soc. Jpn. 1976;49:3213.

Miller AL. Botanical influence on cardiovascular disease Alt. Med. Rev 1998; 3:422.

Kusumoto I, Nakabayashi T, Kida H, et al. Screening of various plant extracts used in ayurvedic medicine for inhibitory effects on human immunodeficiency virus type 1 (HIV-1)protease. Phytotherapy Res. 1995;9:180-184.

Jain V, Poonia, A, Agarwal RP, Panwar RB, Kochar DK, Mishra SN. Effect of Terminalia arjuna in patients of angina pectoris (A clinical trial). Indian Medical Gazette (New Series). 1992;36:56–59.

Chopra NR, Nayar SL, Chopra IC. Glossary of Indian Medicinal plants, New Delhi: C.S.I.R Publication. 1956;241.

Bhava mishra, Bhavaprakasha, Choukhamba publications , Varanasi; 1998.

Orwa C, Mutua A, Kindt R, Jamnadass R, Simons A. Agroforestree Database:a tree reference and selection guide version 4.0; 2009. Available:

Shah CS, Bhavsar GC, Pharmacognosy of the bark of Terminalia tomentosa W&A and comparison with Terminalia arjuna W&A bark. Indian Journal of Pharmacology 1956; 18:81–84.

Prasad S. Histology of the bark of Terminalia arjuna. Indian Journal of Pharmacology. 1941; 3:114–121.

Charak Samhita. Vaidya Jadavaji Trikamji Acharya, Chakrapani with commentary, Sutra 27 Bombay:Nirnaya Sagar Press, India. 1941:173 (reprinted by Chaukhamba Sanskrit Sansthan, Varanasi, India, 1984).

Bajpeyee, J. (Ed.), Chakradutta. Venkateshwar Press, Bombay, India; 1959.

Bhawa Prakash, Lal Chandra Vaidya (Ed.), 3rd ed. Motilal Benarasi Das, Varanasi, India. 1963; 218.

Nadkarni AK, Nadkarni KM. Indian Materia Medica, 1st ed. Popular Book Depot, Bombay India. 1954:1198.

Warrier PK, Nambiar VPK, Ramankutty C. Terminalia arjuna. In:Warrier, P.K., Nambiar, V.P.K., Ramankutty, C. (Eds.), Indian Medicinal Plants—A Compendium of 500 Species, vol. 5, 1st ed. Orient Longman Limited, Madras, India. 1996;5:253–257.

Amalraj A,Gopi S. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.:A review. Journal of Traditional and Complementary Medicine. 2016;7(1):65-78.

Dymock WM, Warden GH,Hooper D, Pharmacographica India. Thodkar Spink Company, London; 1891.

Ghoshal LM, Terminalia arjuna. Ph.D. thesis, Calcutta University, Calcutta, India; 1909.

Chopra RN, Ghosh S. Terminalia arjuna:its chemistry, pharmacology and therapeutic action. Indian Medical Gazette. 1929;64:70–73.

Ghosh S. Annual report of the Calcutta School of Tropical Medicine. Institute of Hygiene and the Carmichel Hospital for Tropical Diseases, Calcutta, India; 1926.

King FE, King TJ, Ross JM. The constitution of Arjunolic acid, a triterpene from Terminalia arjuna. J Chem Soc. 1954;23:3995.

Honda T, Murae T, Tsuyuki T, Takahashi T. The structure of arjungen:a new sapogenin from Terminalia arjuna. Chemical & Pharmaceutical Bulletin. 1976a;24:178–180.

Honda T, Murae T, Tsuyuki T, Takahashi T, Sawai M. Arjungenin, arjunglucoside I and arjunglucoside II, a new triterpene and new triterpene glycosides from Terminalia arjuna. Bulletin of the Chemical Society of Japan. 1976b;49:3213–3218.

Kumar R, Verma RK. New host records of some foliicolous fungi from India. Indian Phytopathology. 1987;40:274.

Pettit GR, Hoard MS, Doubek DL, Schmidt JM, Pettit RK, Tackett LP, Chapuis JC. Antineoplastic agents 338. The cancer cell growth inhibitory constituents of Terminalia arjuna (Combretaceae). Journal of Ethnopharmacology. 1996;53:57–63.

Nair S, Nair R, Gupta R. Dietary antioxidant, phenolics and flavonoids in coronary heart disease (Abstract). Indian Heart Journal. 1996;48:545.

Lin TC, Chien SC, Chen HF, Hsu FL. Tannins and related compounds from Combretaceae plants. Chinese Pharmaceutical Journal. 2001;52:1–26.

Ali A, Kaur G, Hayat K, Ali M, Ather M. A novel naphthanolglycoside from Terminalia arjuna with antioxidant and nitric oxide inhibitory activities. Pharmazie. 2003a;58: 932–934.

Ali A, Kaur G, Hamid H, Abdulla T, Ali M, Niwa, Alam MS. Terminoside A, a new triterpene glycoside from the bark of Terminalia arjuna inhibits nitric oxide production in murine macrophages. Journal of Asian Natural Product Research. 2003b;5:137–142.

Bajpai M, Pande A, Tewari SK, Prakash D. Phenolic contents and antioxidant activity of some food and medicinal plants. International Journal of Food Science and Nutrition. 2005;56:287–291.

Patnaik T, Dey RK, Panchanan G. Isolation of triterpenoid glycoside from bark of Terminalia arjuna using chromatographic technique and investigation of pharmacological behavior upon muscle tissues. E-Journal of Chemistry. 2007; 4:474- 479.

Morshed MA, Uddin A, Rahman A, Hasan T, Roy S, Amin AA, Ahsan R, Islam R. In vitro antimicrobial and cytotoxicity screening of Terminalia arjuna ethanol extract. International Journal of Biosciences (IJB). 2011;1:31-38.

Patil UH, Gaikwad DK. Phytochemical evaluation and bactericidal potential of Terminalia arjuna stem bark. International Journal of Pharmaceutical Science and Research. 2011;2(3):614-619.

Mety SS, Mathad P. Antioxidative and free radical scavenging activities of Terminalia species. International Research Journal of Biotechnology (ISSN:2141-5153). 2011; 2(5):119-127.

Anjaneyulu, ASR, Prasad AVR, Structure of terminic acid, a dihydroxy triterpene carboxylic acid from Terminalia arjuna. Phytochemistry. 1983;22:993–998.

Choubey BK, Srivastava SK. Antifungal agents from Terminalia arjuna. Indian J Chem. 2001;40B:354-356.

Nadkarni AK. Indian Materia Medica. 1st ed. Mumbai, India:Popular Prakashan; 1976.

Gupta LP, Studies on cardiac muscle regeneration under the influence of certain indigenous drugs. Ph.D. thesis, Banaras Hindu University, Varanasi, India; 1974.

Gupta LP, Sen SP, Udupa KN. Pharmacological studies on Terminalia arjuna. Journal of Research in Indian Medicine, Yoga and Homeopathy. 1976;11:16–24.

Bhatia J, Bhattacharya SK, Mahajan P, Dwivedi S. Effect of Terminalia arjuna on coronary flow—an experimental study (Abstract). IndianJournal of Pharmacology 1998; 30:118- 120.

Srivastava RD, Dwivedi S, Sreenivasan KK, Chandrashekhar CN. Cardiovascular effects of Terminalia species of plants.Indian Drugs 1992; 29:144–149.

Radhakrishnan R, Wadsworth RM, Gray AI. Terminalia arjuna, an Ayurvedic cardiotonic, increases the contractile force of rat isolated atria. Phytother Res. 1993;7:266– 268.

Karamsetty M, Ferrie TJ, Kane KA, Gray AI. Effects of an aqueous extract of Terminalia arjuna on isolated rat atria and thoracic aorta. Phytother Res. 1995;9:575–578.

Colabawalla HM. An evaluation of the cardiotonic and other properties of Terminalia arjuna. Ind Heart J. 1951;3:205–230.

Singh N, Kapur KK, Singh SP, Shankar K, Sinha JN, Kohli RD. Mechanism of cardiovascular action of Terminalia arjuna. Planta Med. 1982;45:102–104.

Bhatia J, Bhattacharya SK, Mahajan P, Dwivedi S. Effect of Terminalia arjuna on blood pressure of anesthetized dogs (Abstract). Indian J Pharmacol. 2000;32:159–160.

Nammi S, Gudavalli R, Babu BS, Lodagala DS, Boini KM. Possible mechanism of hypotension produced by 70% alcoholic extract of Terminalia arjuna (L.) in anesthetized dogs. BMC Complementary and Alternative Medicine; 2003.

Dwivedi S, Somani PN, Chansouria JPN, Udupa KN, Cardioprotective effects of certain indigenous drugs in myocardial ischemia in rabbits. Indian Journal of Experimental Biology. 1988;26:969–975.

Tandon S, Rastogi R, Kapoor NK. Protection by abana, a herbomineral preparation, against myocardial necrosis in rats induced by isoproterenol. Phytotherapy Research. 1995;9:263–266.

Sumitra M, Manikandan P, Kumar DA, Arutselvan N, Balakrishna K, Manohar BM, Puvanakrishnan R. Experimental myocardial necrosis in rats:role of arjunolic acid on platelet aggregation, coagulation, and antioxidant status. Molecular and Cellular Biochemistry. 2001; 224:135–142.

Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SK. Effect of chronic treatment with the bark of Terminalia arjuna:a study on the isolated ischemic-reperfused rat heart. Journal of Ethnopharmacology. 2001;75:197–201.

Kumar S, Enjamoori R, Jaiswal A, Ray R, Seth S, Maulik SK. Catecholamine-induced myocardial fibrosis and oxidative stress are attenuated by Terminalia arjuna (Roxb.). J Pharm Pharmacol. 2009; 61:1529–1536.

Tiwari AK, Gode JD, Dubey GP. Effect of Terminalia arjuna on lipid profiles of rabbit fed hypercholesterolemic diet. International Journal of Crude Drug Research. 1990;28:43–47.

Pathak SR, Upadhya L, Singh RN, Effect of Terminalia arjuna on lipid profile of rabbit fed hypercholesterolemic diet. International Journal of Crude Drug Research. 1990;28:48–51.

Ram A, Lauria P, Gupta R, Kumar R, Sharma VS. Hypocholesterolemic effects of Terminalia arjuna tree bark. Journal of Ethnopharmacology. 1997;55:165–169.

Khanna AK, Chander C, Kapoor NK. Terminalia arjuna:an Ayurvedic cardiotonic regulates lipid metabolism in hyperlipidemic rats. Phytotherapy Research. 1996;10:663–665.

Shaila HP, Udupa SL, Udupa AL. Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. International Journal of Cardiology. 1998;67:119–124.

Parmar HS, Panda S, Jawa R, Kar A. Cardioprotective role of Terminalia arjuna bark extract is possibly mediated through alterations in thyroid hormones. Pharmazie. 2006;61:793-795.

Devasagayan TPA, Tarachand U, Decrease lipid peroxidation in rat kidney during gestation. Biochem. Biophys. Res. Comm. 1987;145:134-138.

Karthikeyan K, Bai BR, Gauthaman K, Sathish KS, Devaraj SN. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life Sciences. 2003;73:2727– 2739.

Pawar RS, Bhutani KK. Effect of oleanane triterpenoids from Terminalia arjuna- a cardioprotective drug on the process of respiratoryoxyburst. International Journal of Phytomedicine and Phytopharmacology. 2005;12:391–393.

Singh S, Latheef SAA, Subramanyam G, Muralikrishna P, Selective protection of LDL against oxidation (Abstract). In:Proceedings of the 15th Annual Conference of the Indian Society of Hypertension Abstract Book, UCMS-GTB Hospital, Delhi, India, 2005; 12–13 November, p. 68.

Ghanekar BG, Ayurveda Rahasyadipika, in Sushruta Samhita with Hindi commentary Sutra and Midansthan (Mehar chandLaccmandas, Lahore). 1936;213.

Chaudhari M, Mengi S. Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats. Phytotherapy Research. 2006;20:799–805.

Thiagarajan H, Sivasami P, Chidambaram B, Bhakthavatsalam MM, Rengarajulu P. Arjunolic acid:A novel phytomedicine with multifunctional therapeutic applications. Indian Journal of Experimental Biology. 2010;48:238-247.

Manna P, Sinha M, Sil PC. Protective role of arjunolic acid in response to streptozotocin-induced type- Ι diabetes via the mitochondrial-dependent and independent pathways. Toxicology. 2009; 257:53.

Prasad MVV, Anbalagan N, Patra A, VeluchamyG, Balakrishna K. Antiallergic and anti-asthmatic activities of the alcoholic extract of Terminalia arjuna and arjunolic acid. Nat Prod Sci. 2004; 10:240.

Summer R, Sigler R, ShelhamerJH, Kaliner M. Effect of infused histamine on the asthmatic and normal subject; comparison of skin test responses. J Allergy Clin Immunol. 1981;67:456.

Akah PA, Ezike AC, Nwafor SV, Ololiad CO, Enwerem NM. Evaluation of asthmatic property of astasia gangetic leaf extract. J Ethnopharmacol. 2003;89:25.

Jamieson ER, Lippard SJ. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem Rev. 1999;99:2467-2498.

Sivalokanathan S, Ilyaaraja M, Balasubramanian MP. Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Molecular and Cellular Biochemistry. 2006;281:87–93.

Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y, Yabu Y. Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. BiochemBiophys Res Commun. 1994;204:898-904.

Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of mouth cancer:a review of global incidence. Oral Dis. 2000;6(2):65-74.

Dhanarasu S, Mathi S, Suzan M, Abdel-Tawab S, Manoharan S, Prema S.Terminalia Arjuna (Roxb.) Modulates Circulatory Antioxidants on 7, 12-dimethylbenz (a)anthracene-induced Hamster Buccal Pouch Carcinogenesis. Oman Medical Journal. 2010;25(4):276-281.

Gali HU, Perchellet EM, Perchellet JP. Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis invivo. Cancer Res. 1991;51:2820-2825.

Nagpal A, Meena LS, Kaur S, Grover IS, Wadhwa R, Kaul SC. Growth suppression of human transformed cells by treatment with bark extracts from a medicinal plant, Terminalia arjuna. In Vitro Cell Dev Biol Anim. 2000;36:544- 547.

Singh DV, Gupta MM, Santha TR, Kumar S, Khanuja SPS. Antibacterial principles from the bark of Terminalia arjuna,Current Science. 2008;94:1- 10.

Fakruddin M, Alam KMA, Mazumdar RM, Islam S, Nipa MN, Iqbal A, Bhuiyan HR.Anti-bacterial activity of the extract of Terminalia arjuna against multi antibiotic-resistant Vibrio cholera. Journal of Scientific Research. 2011;3(1):129-137.

Benowitz NL, Cardiotoxicity in the workplace. Occup med 1992;7:465.

Manna P, Sinha M, Sil PC. Arsenic-induced oxidative myocardial injury; the protective role of arjunolic acid. Arch Toxicol. 2008;82:137.

Manna P, Sinha M, Sil PC. Protection of arsenic-induced hepatic disorder by arjunolic acid. Basic Clin PharmacolToxicol. 2007;101:333.

Sinha M, Manna P, Sil PC. Arjunolic acid attenuates arsenic-induced nephrotoxicity. Pathophysiology. 2008;15:147.

Manna P, Sinha M, Sil PC. Protection of arsenic-induced testicular oxidative stress by arjunolic acid. Redox Rep. 2008;13:67.

Ghosh J, Das J, Manna P, Sil PC. Cytoprotective effect of arjunolic acid in response to sodium fluoride mediated oxidative stress and cell death via a necrotic pathway. Toxicol in vitro. 2008; 22:1918.

Ghosh J, Das J, Manna P, Sil PC. Acetaminophen-induced renal injury via oxidative stress and TNF α production:therapeutic potential of arjunolic acid. Toxicology. 2009;13. (in press).

Reddy T K, Seshadri P, Reddy KK, Jageta GC, Reddy CD. Effect of Terminalia arjuna extract on adriamycin-induced DNA damage, Phytother Res. 2008;22(9):1188-94

Dwivedi S, Udupa N. Terminalia arjuna:pharmacognosy, phytochemistry, pharmacology, and clinical use. A review. Fitoterpia. 1989;60:413–420.

Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug in coronary artery disease. Journal of Association of Physicians of India. 1994; 42:287–289.

Bharani A, Ganguli A, Bhargava, KD. The salutary effect of Terminalia arjuna in patients with severe refractory heart failure. International Journalof Cardiology. 1995;49:191–199.